Executive record
Sam Martin
Most recent record: Celldex Therapeutics, Inc. discloses CFO departure: Sam Martin (named as the outgoing officer), effective March 31, 2027. See Celldex Therapeutics, Inc..
1 verified record
This page lists only verified filing records that name Sam Martin; it is not a career history. Corrections: the corrections page.